SubHero Banner
Text

1st Quarter 2022

Key topics in this quarter’s edition include:

  • Vutrisiran for polyneuropathy of hereditary transthyretin-mediated amyloidosis
  • Tapinarof for plaque psoriasis
  • Tirzepatide for type 2 diabetes mellitus
  • AMX-0035 (sodium phenylbutyrate/taurursodiol) for amyotrophic lateral sclerosis

Download PDF

Text